Volume | 212,564 |
|
|||||
News | - | ||||||
Day High | 0.8199 | Low High |
|||||
Day Low | 0.72 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Sensei Biotherapeutics Inc | SNSE | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.7323 | 0.72 | 0.8199 | 0.7396 | 0.755 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
466 | 212,564 | $ 0.7532139 | $ 160,106 | - | 0.51 - 1.94 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:55:10 | 7 | $ 0.7799 | USD |
Sensei Biotherapeutics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
19.05M | 25.07M | - | 0 | -34.1M | -1.36 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Sensei Biotherapeutics News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SNSE Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.89 | 0.89 | 0.6876 | 0.800325 | 645,005 | -0.1101 | -12.37% |
1 Month | 1.76 | 1.94 | 0.6876 | 1.31 | 360,457 | -0.9801 | -55.69% |
3 Months | 0.97 | 1.94 | 0.6876 | 1.35 | 254,739 | -0.1901 | -19.60% |
6 Months | 0.6729 | 1.94 | 0.59775 | 1.23 | 148,229 | 0.107 | 15.90% |
1 Year | 1.48 | 1.94 | 0.51 | 1.16 | 91,791 | -0.7001 | -47.30% |
3 Years | 12.47 | 13.00 | 0.51 | 3.44 | 85,645 | -11.69 | -93.75% |
5 Years | 24.70 | 26.38 | 0.51 | 6.15 | 98,066 | -23.92 | -96.84% |
Sensei Biotherapeutics Description
Sensei Biotherapeutics Inc is a clinical-stage immunotherapy company. It is engaged in the discovery and development of next-generation therapies with an initial focus on treatments for cancer. The company's ImmunoPhage platform is a powerful, self-adjuvanted and highly differentiated immunotherapy approach that is designed to utilize bacteriophage to induce a robust, focused, and coordinated innate and adaptive immune response. |